ECRI bv   Report issue

Foundation Phase 3 Phase 4
Founded: Rotterdam Netherlands (2012)

Organization Overview

First Clinical Trial
2013
NCT01813435
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

ECRI bv